Patrick Soon

TheStreet.comPatrick Soon-Shiong: NantKwest is starting down the path to conquering cancerFierceBiotechPatrick Soon-Shiong made several fortunes based on his understanding of cancer and drug development, most recently in today's multibillion-dollar IPO for NantKwest ($NK). And now he plans to put the IPO money to use in pursuit of a new strategy in ...Struggling Sanofi Sends Cancer SOS to Regeneron and Another Vanity Biotech IPO ...TheStreet.comall 29 news articles »

Share this post